1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60:277–300.
Article
2. Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007; 57:253–60.
Article
3. Sorensen JB, Hansen HH, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol. 1988; 6:1474–80.
4. Chang KH, Song CE, Seo JH, Yeo SW. Solitary metastasis of bronchogenic adenocarcinoma to the internal auditory canal: a case report. J Korean Med Sci. 2009; 24:1227–9.
Article
5. Schrock A, Laffers W, Bootz F. Solitary metastasis of lung carcinoma to the internal auditory canal. Am J Otolaryngol. 2006; 27:214–6.
Article
6. Kang SJ, Kim KS, Ha YS, Huh SY, Lee JH, Kim JK, et al. Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis. J Clin Neurol. 2010; 6:33–7.
Article
7. Moffat DA, Saunders JE, McElveen JT Jr, McFerran DJ, Hardy DG. Unusual cerebello-pontine angle tumours. J Laryngol Otol. 1993; 107:1087–98.
Article
8. Streitmann MJ, Sismanis A. Metastatic carcinoma of the temporal bone. Am J Otol. 1996; 17:780–3.
9. Yoda S, Cureoglu S, Paparella MM. Pulmonary carcinoma metastasis to the internal auditory canal. Otol Neurotol. 2011; 32:e48–9.
Article
10. Loo SW, Dean AF, Murray P. Internal auditory canal metastasis mimicking a vestibular schwannoma at presentation: a case report and review of the literature. Int Semin Surg Oncol. 2009; 6:8.
Article
11. Krainik A, Cyna-Gorse F, Bouccara D, Cazals-Hatem D, Vilgrain V, Denys A, et al. MRI of unusual lesions in the internal auditory canal. Neuroradiology. 2001; 43:52–7.
Article
12. Umemura S, Tsubouchi K, Yoshioka H, Hotta K, Takigawa N, Fujiwara K, et al. Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group. Lung Cancer. 2012; 77:134–9.
Article
13. Heon S, Yeap BY, Britt GJ, Costa DB, Rabin MS, Jackman DM, et al. Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib. Clin Cancer Res. 2010; 16:5873–82.
Article